Catalist listed Aoxin Q&M Dental Limited (“Aoxin” or “the Group”), today announced a 20.8% increase in revenue to RMB160.2 million…
Catalist listed Aoxin Q&M Dental Limited (“Aoxin” or “the Group”), today announced a 20.8% increase in revenue to RMB160.2 million…
Q&M Dental Group (Singapore) Limited (“Q&M” or together with its subsidiaries, the “Group”), a leading private dental healthcare group in…
Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. (“Acumen Diagnostics” or the “Company”), a 51% owned subsidiary of Q&M Dental…